Marissa Jarosinski: Clinical Trials

1 trial sponsored by Marissa Jarosinski, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Marissa Jarosinski: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions
Point of care screening for HPR, Ticagrelor 90mg - Peripheral Artery Disease, Clopidogrel, Poor Metabolism of
Phase 3TerminatedMarissa Jarosinski312019-08-092026-07-06

Conditions studied

Peripheral Arterial Disease (1)  ·  Peripheral Arterial Occlusive Disease 1 (1)  ·  Peripheral Vascular Diseases (1)

Interventions

Ticagrelor (1)

Countries

United States (1)